Literature DB >> 2332595

Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis.

D Alvaro1, M Angelico, C Gandin, S Ginanni Corradini, L Capocaccia.   

Abstract

Liver cirrhosis is associated with a high prevalence of pigmentary cholelithiasis. The major compound of pigment gallstones is unconjugated bilirubin (UCB) in the form of calcium bilirubinate salts or a black pigment polymer. Most of UCB in bile derives from enzymic or non-enzymic hydrolysis of mono- or diconjugated bilirubin. Changes in the relative ratios between these two bilirubin species have been associated with pigment gallstones. It has also been shown that UCB solubilization in bile depends on its interaction with bile salts. In order to clarify the factors predisposing cirrhotic patients to pigment stone formation, we measured UCB, monoconjugated bilirubin (MCB) and diconjugated bilirubin (DCB) in duodenal bile of 15 patients with cirrhosis, ten patients with chronic active hepatitis (CAH) and ten normal subjects, we also analyzed their relationships with lipids. In cirrhotic patients, the MCB concentration in bile was significantly (p less than 0.05) higher than in normal subjects and was correlated with the severity of the disease. Bile salts and lecithin concentrations were significantly lower in cirrhosis (p less than 0.005 vs. CAH or normals). Cirrhotic patients have a bile salts/UCB molar ratio which is one third that of CAH patients or normal subjects (p less than 0.01). No differences were found between CAH patients and controls in each of the parameters tested. In conclusion, we propose that the very low BS/UCB molar ratio and the very high biliary content in MCB represent two independent physico-chemical factors predisposing cirrhotic patients to pigmentary cholelithiasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332595     DOI: 10.1016/0168-8278(90)90057-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital.

Authors:  Chi-Ming Liu; Tao-Hsin Tung; Pesus Chou; Victor Tze-Kai Chen; Chung-Te Hsu; Wu-Shyong Chien; Yeu-Tyng Lin; Hsu-Feng Lu; Hui-Chuan Shih; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

2.  Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.

Authors:  C P Li; S J Hwang; F Y Lee; F Y Chang; H C Lin; R H Lu; C J Chu; S D Lee
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Autonomic dysfunction and cholelithiasis in patients with cirrhosis.

Authors:  A Chawla; L Puthumana; P J Thuluvath
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide.

Authors:  Zhen-Hai Zhang; Cheng-Kun Qin; Shuo-Dong Wu; Jian Xu; Xian-Ping Cui; Zhi-Yi Wang; Guo-Zhe Xian
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 5.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 6.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 8.  Gallstones in Patients with Chronic Liver Diseases.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Ge Yu; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

9.  Epidemiology of gallbladder disease: cholelithiasis and cancer.

Authors:  Laura M Stinton; Eldon A Shaffer
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.